AGARWAL SUNIL 4
4 · Sana Biotechnology, Inc. · Filed Sep 17, 2021
Insider Transaction Report
Form 4
AGARWAL SUNIL
See Remarks
Transactions
- Sale
Common Stock
2021-09-15$26.07/sh−58,373$1,521,755→ 1,551,627 total - Sale
Common Stock
2021-09-16$26.00/sh−1,627$42,302→ 1,550,000 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 5, 2021.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.00 to $26.225, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.